Results 141 to 150 of about 5,863 (219)

Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network. [PDF]

Clin Infect Dis
Atmar RL, Abate G, Deming ME, George SL, Fleming A, Frey SE, Lyke KE, Stephens DS, Del Rio C, El Sahly HM.   +9 more
europepmc   +1 more source

Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials [PDF]

, 2012
Fabio Bagnoli, Guido Grandi, Sylvie Bertholet   +2 more
core   +2 more sources

Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines. [PDF]

J Funct Biomater
Liu X, Yang X, Tao L, Li X, Chen G, Liu Q.   +5 more
europepmc   +1 more source

Photoconverted cells allow rapid assessment of vaccine adjuvant potency in mice. [PDF]

iScience
Zhong Y, Chen M, Lin H, Zu C, He Y, Wang B.   +5 more
europepmc   +1 more source

Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses. [PDF]

J Virol
Hu Z, Tian S, Zhou Y, Wang Y, Li Y, Zhang S, Wei P, Zhuang Z, Ren L, Liu J, Zang N, Yu R, Ding Y, Guo Y, Jing C, Chen H, Zhang C, Yao Y, Deng C, Wei R, Zhou P, Zou Y, Zhao D, Liu S, Fu M, Mo X, Peng G, Liu E, Zhao J, Li Y, Jin J.   +30 more
europepmc   +1 more source

The recent advances in vaccine adjuvants. [PDF]

Front Immunol
Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, Song N.   +6 more
europepmc   +1 more source

Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. [PDF]

Transpl Infect Dis
Hayek H, Hasan L, Amarin JZ, Qwaider YZ, Hamdan O, Rezende W, Dee KC, Chappell JD, Halasa NB.   +8 more
europepmc   +1 more source

The nanoemulsion adjuvant provides antigen dose-sparing effects and enhances maternal passive immune protection for the cell-cultured quadrivalent influenza virus subunit vaccine. [PDF]

Virol J
Wang Y, Jia Z, Liu Y, Li S, Qiao Y, Zhao D, Gu J, Wu Y.   +7 more
europepmc   +1 more source

Adjuvanted Recombinant Hemagglutinin Vaccine Provides Durable and Broad-Spectrum Immunogenicity in Mice. [PDF]

Vaccines (Basel)
Yu R, Guo Y, Zhang S, Ai Y, Wei R, Li Y, Chen H, Liu S, Zhang C, Yao Y, Lv M, Li Y, Chen Y, Zhou P, Tu S, Fu M, Su Y, Lin Y, Yang M, Ding Y, Tian S, Jing C, Chen H, Ma T, Deng C, Zhou Y, Li Y, Jin J.   +27 more
europepmc   +1 more source

Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines. [PDF]

Adv Drug Deliv Rev
Wang Y, Sun D, Laney V, Wang H, Wang LL, Lu ZR.   +5 more
europepmc   +1 more source